CVS Stock Plunges as Medicare Advantage Costs Spike

CVS Health (CVS) stock plummeted more than 18% at the start of Wednesday's trading session after the pharmacy chain disclosed weaker-than-expected earnings and revenue for its first quarter and slashed its full-year outlook.In the three months ended March 31, CVS reported revenue of $88.4 billion, an increase of 3.7$32.2 billion. However, earnings per share (EPS) decreased 40.5% year-ov ...